TABLE 5.
Proteaseb | Mean cleavage efficiency (%) ± SD
|
|
---|---|---|
FIV DU/IN peptide (TGVF/SSWV) | P1′-S peptide (SGVF/SVNG) | |
Wild-type FIV | 76.3 ± 11.9 | 80.4 |
Mutants | ||
Q99V | 67.9 ± 6.6 | 82.2 |
37/55/56/59 | 2.8 ± 0.9 | 29.9 |
55/56/59/99 | 1.8 ± 1.0 | 24.8 |
37/55/56/59/99 | 1.6 ± 0.8 | 31.9 |
37/55/56/59/98/99 | 2.3 ± 1.1 | 25.7 |
Wild-type HIV | 1.5 ± 1.0 | 5.0 |
The determinant was probed by assaying the cleavage activity of the panel of mutants as described in Table 4 on two peptides that contain Ser at the P1′ position. These peptides were cleaved cleaved efficiently by FIV PR but poorly by HIV-1 PR. All assays were done with 150 nM PR. The incubation time for the FIV dUTPase/integrase (DU/IN) junction peptide was 25 min and for phage peptide (SGVF/SVNG) was 30 min.
See Table 1, footnote a.